Human IL-3

Recombinant human IL-3 (interleukin 3) can promote proliferation, survival, and differentiation of hematopoietic stem cells and committed progenitor cells of the myeloid or megakaryocyte lineage. This includes cells of the basophilic, megakaryocyte, erythroid, eosinophilic, monocytic, and mast cell lineage. Suitable for use in cell culture, functional assays, and differentiation studies, the recombinant human IL-3 is ideal for research.

Select a quality grade:
Select a size:
Other sizes

Related products for Human IL-3

Product data and images for Human IL-3
Figure 1

Human IL-3 activity assay. The biological activity of Human IL-3, premium grade was determined by proliferation assay using TF-1 cells.

Figure 2

SDS-PAGE of Human IL-3, premium grade from Miltenyi Biotec (MB) in comparison to recombinant human IL-3 from a different supplier (S), both under reducing and non-reducing conditions.

Figure 3

Mass spectrometry analysis (ESI-MS) of Human IL-3, premium grade. The peak corresponds to the calculated molecular mass of 15089 Da.

Specifications for Human IL-3
Overview

Recombinant human IL-3 (interleukin 3) can promote proliferation, survival, and differentiation of hematopoietic stem cells and committed progenitor cells of the myeloid or megakaryocyte lineage. This includes cells of the basophilic, megakaryocyte, erythroid, eosinophilic, monocytic, and mast cell lineage. Suitable for use in cell culture, functional assays, and differentiation studies, the recombinant human IL-3 is ideal for research.

Applications

Human IL-3 can be used for a variety of applications, including:

  • Induction of colony formation from hematopoietic progenitor cells in semi-solid medium in vitro, for example, CD34+ cells from umbilical cord blood2.
  • In vitro differentiation studies, for example, of B lymphoid progenitors3.
  • Cultivation of plasmacytoid dendritic cells4.
  • In vitro expansion of hematopoietic stem cells.
  • Investigation of mast cell or basophil function, for example, basophil interaction with blood vessels5.
  • Investigation of IL-3–mediated signaling pathways.
Detailed product information

Biological activity

Determination method
Proliferation of TF-1 cells (NIBSC 91/510)
Research grade
≥ 1×106 IU/mg
Premium grade
≥ 2×106 IU/mg (Typical activity 2.3×106 IU/mg)
We measure the biological activity of each batch of MACS Premium-Grade Cytokines and state the results in the Certificate of Analysis (CoA). Based on the lot-specific activity, exact doses of active cytokine can be applied to cell culture experiments. This allows for reproducible cell culture conditions without the need for time-consuming lot-to-lot testing.
Background information

Interleukin 3 (IL-3) is a hematopoietic growth factor, which is produced mainly by activated T cells, but is also secreted by other cell types, including mast cells, eosinophils, and keratinocytes. The broad spectrum of biological activities of IL-3 includes the stimulation of the proliferation and differentiation of immature pluripotent hematopoietic stem cells and various lineage-committed progenitor cells, leading to the production of most of the major blood cell types. In addition, IL-3 also affects the functional activity of mature mast cells, basophils, eosinophils, and macrophages.

Quality description

Research-grade cytokines are suitable for a wide variety of cell culture applications. They are sterile-filtered prior to lyophilization. Generally, endotoxin levels are <0.1 ng/μg (<1 EU/μg), and purities are >95%. The biological activity is tested in appropriate bioassays.

Premium-grade cytokines offer the convenience of high and well-defined biological activities and allow exact unit dosing for demanding applications. The biological activity is determined after lyophilization and reconstitution, and normalized to WHO/NIBSC standards whenever available. In general, endotoxin levels are <0.01 ng/μg (<0.1 EU/μg), and purities are >97%. Lot-specific activities are stated in the Certificate of Analysis (www. miltenyibiotec.com/certificates).

Resources for Human IL-3
Documents and Protocols
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for Human IL-3
Publications
  1. Kitamura, T. et al. (1989) Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol. 140: 323-334
  2. Laurenti, E. et al. (2015) CDK6 levels regulate quiescence exit in human hematopoietic stem cells. Cell Stem Cell 16 (3): 302-313
  3. Cordes, N. et al. (2021) Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells. Mol Ther Methods Clin Dev 21: 42-53
  4. Moussy, A. et al. (2017) Integrated time-lapse and single-cell transcription studies highlight the variable and dynamic nature of human hematopoietic cell fate commitment. PLoS Biol. 15 (7): e2001867
  5. Geeraerts, S. L. et al. (2021) Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis-Addicted Breast Tumor Growth. Mol Cancer Ther. 20 (1): 50-63
  6. Cassuto, O. et al. (2012) All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to ponatinib. Oncotarget. 3 (12): 1557-1567
  7. Rossmanith, T. et al. (2001) Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of SCID repopulating cells. Stem Cells 19: 313-320
  8. Dighe, N. et al. (2014) Long-term reproducible expression in human fetal liver hematopoietic stem cells with a UCOE-based lentiviral vector. PLoS One 9 (8): e104805
  9. Narla, A. et al. (2011) Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis. Blood 118 (8): 2296-2304
  10. Tas, S. W. et al. (2007) Noncanonical NF-kappaB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation. Blood 110: 1540-1549
  11. Nakazawa, Y. et al. (2016) Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34(+) cells of juvenile myelomonocytic leukemia. J Hematol Oncol. 9: 27
  12. Aires, V. et al. (2021) CD22 Blockage Restores Age-Related Impairments of Microglia Surveillance Capacity. Front Immunol 12: 684430
  13. Lim, L. H. et al. (2006) Stimulation of human endothelium with IL-3 induces selective basophil accumulation in vitro. J Immunol 176: 5346-5353
  14. Jing, D. et al. (2010) Hematopoietic stem cells in co-culture with mesenchymal stromal cells--modeling the niche compartments in vitro. Haematologica 95 (4): 542-550
  15. Chae, H.-D. et al. (2020) RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit. Oncotarget. 11 (25): 2387-2403
  16. Bianchi, E. et al. (2015) MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF. Cell Death Differ. 22 (12): 1906-1921
  17. Brault, J. et al. (2014) Optimized generation of functional neutrophils and macrophages from patient-specific induced pluripotent stem cells: ex vivo models of X0-linked, AR220- and AR470- chronic granulomatous diseases. Biores Open Access 3 (6): 311-326
  18. Munitión, S. et al. (2016) Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients. PLoS One 11 (2): e0146722
  19. Youn, M. et al. (2017) Loss of Forkhead box M1 promotes erythropoiesis through increased proliferation of erythroid progenitors. Haematologica 102 (5): 826-834
  20. Steinleitner, K. et al. (2012) EVI1 and MDS1/EVI1 expression during primary human hematopoietic progenitor cell differentiation into various myeloid lineages. Anticancer Res. 32 (11): 4883-4889
  21. Xie, Z. S. et al. (2019) Sphingolipid Modulation Activates Proteostasis Programs to Govern Human Hematopoietic Stem Cell Self-Renewal. Cell Stem Cell 25 (5): 639-653
  22. Crooks, G. M. et al. (2000) IL-3 increases production of B lymphoid progenitors from human CD34+CD38– cells. J Immunol 165: 2382-2389

You have previously chosen International as your location.
What do you want to do?